Saturday 17 June 2017

The Right Opioid Dosing And Avoiding The Addiction Trap

By Kevin Graham


The miracle of opioid pain relief is fatally limited by tolerance, addiction, and respiratory depression. Buprenorphine, when combined with a mu agonist, results in game-changing effects. Patients experience potent, dose-related analgesia from the agonist, but have NO euphoria. The therapeutic window is widened. Patients unable to control their use of a mu agonist alone gain that control when on buprenorphine. And most exciting, buprenorphine indefinitely anchors tolerance, maintaining analgesia WITHOUT DOSE ESCALATION. This finding offers huge implications for pain management and opioid dosing.

Opioid medications are prescribed for patients with painful conditions and the response is typically excellent pain relief. There are side effects which may include constipation, tolerance, depression, and sedation. With chronic pain affecting 15% of the US population, doctors are prescribing narcotic medications with alarming frequency.

Because of methadone's slow release, individuals who seek a fast high might take a dose, not get a high then consume more. By the time they get high, in a few instances, they've already consumed too much. Odds of revival are a lot lower for overdose of methadone than for additional opiates because of the long lasting nature of the drug. If you believe somebody has overdosed on this drug, contact 911 and immediately get them emergency assistance.

Research shows narcotic use is higher among the less educated and unemployed. A recent report in the American Journal of Medicine specifically looked at fibromyalgia patients receiving opioids for their pain. There was an increased incidence of unemployment, disability payments, and history of substance abuse. Also, the statistics showed overall lower education and an increased incidence of unstable psychiatric disorders. The study was not small and contained over 450 patients, so the results were most likely valid despite potential statistical variances.

Interestingly, there were 2 factors that lead to the continued usage. One was if the patient had been prescribed the drugs before, and the other was if the patients were prescribed doses in excess of 120 milligrams of morphine. Of note, that is a hefty dose.

Beginning a patient on a high methadone dose or raising the dosage too rapidly may put the individual in jeopardy of an accidental overdose. Well-managed, high-quality centers carefully will observe their patients while in the induction and cooperate with them to get them to a dosage level that is comfortable as soon as possible, yet without taking unneeded risks.

Sleep is affected significantly by opioids. A large review of studies was published in Postgraduate Medicine looking at the effect of narcotics on sleeping patterns. What popped out? Well, opiate users displayed significant incidence of insomnia, arousals, and wakefulness.

There was also a temporary absence of REM sleep, which is the type of sleep people go into as they go deeper into sleep. So narcotics appear to affect both the quality and quantity of sleep, which is obviously suboptimal for patients who have painful conditions and need sleep for regeneration and healing potential.

Treatment of OIH can be time-consuming, perplexing, and stressful for both the physician and patient. Rotating to a different opiate class may help. Trying non-opioid medications and decreasing opiate dosing is often helpful, along with administering interventional pain treatments to reduce the need for medications or eliminate the need altogether.




About the Author:



No comments:

Post a Comment